MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/13872877251333450

Медицинская библиотека · Journal of Alzheimer's disease : JAD · 2025

Aβ42/40 and p-tau 181 as disease biomarkers in atypical Alzheimer's disease.

Singh-Reilly Neha, Graff-Radford Jonathan, Li Danni, Mielke Michelle M, Machulda Mary M, Schwarz Christopher G, Senjem Matthew L, Jack Clifford R, Lowe Val J, Josephs Keith A, Whitwell Jennifer L

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BackgroundStudies suggest that plasma Alzheimer's disease (AD) biomarkers may aid in the overall diagnosis of AD, but their utility among patients with atypical clinical presentations of AD are unknown.ObjectiveThe main objective of this study was to determine the relationship between amyloid-β (Aβ) and tau plasma biomarkers and PET measures of both Aβ and tau in atypical AD. The secondary objective was to determine if plasma biomarkers could differentiate patients with different atypical AD phenotypes and whether they were related to measures of disease severity.MethodsWe assessed whether plasma p-tau 181 and Aβ42/40 were associated with Aβ and tau PET uptake, clinical phenotype and severity in 77 patients with PET biomarker-confirmed atypical AD.ResultsPlasma Aβ42/40 ratio showed positive associations with tau PET uptake, with higher (more normal) Aβ42/40 ratio associated with higher tau uptake; the ratio was not associated with Aβ PET. No associations were noted with plasma p-tau 181. Plasma Aβ42/40 ratio and p-tau 181 concentrations were not associated with AD phenotype or cognitive severity.ConclusionPlasma Aβ42/40 ratio and p-tau 181 concentrations are not associated with amyloid or tau PET or with clinical severity among individuals presenting with atypical AD.

Для цитирования: Singh-Reilly Neha, Graff-Radford Jonathan, Li Danni, Mielke Michelle M, Machulda Mary M, Schwarz Christopher G, Senjem Matthew L, Jack Clifford R, Lowe Val J, Josephs Keith A, Whitwell Jennifer L. Aβ42/40 and p-tau 181 as disease biomarkers in atypical Alzheimer's disease.. Journal of Alzheimer's disease : JAD. 2025. DOI: 10.1177/13872877251333450.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.